After a period of relative calm, COVID-19 is making a comeback, with a rise in cases reported globally, including in India. While most cases remain mild and patients are recovering at home, health officials are urging caution, particularly for individuals with co-morbidities, pregnant women, and the elderly. The virus's ability to mutate continues to generate new variants with varying transmission patterns and symptom profiles.
One of the most recent variants, known as NB.1.8.1 or "Nimbus," has gained attention due to a prevalent and intensely painful sore throat, often described as "razor blade throat."
The Nimbus variant (NB.1.8.1), a descendant of Omicron, was first identified in January 2025. Since its discovery, it has rapidly spread to numerous countries, including the United States, Canada, the United Kingdom, India, and parts of Asia. The World Health Organization (WHO) currently assesses the variant as mild, not causing severe illness.
A defining characteristic of the Nimbus variant is the severity of throat pain reported by those infected. Patients often describe the sensation as "swallowing razor blades" or "glass," a significant departure from the milder sore throats associated with previous COVID-19 strains.
Doctors suggest that the intense pain arises from the virus causing significant inflammation and irritation of the throat tissues. This leads to a sensation of dryness and cracking, intensifying the pain, especially when eating or drinking.
While a painful sore throat is a hallmark of the Nimbus variant, it typically presents alongside other common COVID-19 symptoms:
These symptoms are consistent with those observed in other Omicron variants.
It's important to note that not all sore throats are indicative of COVID-19. However, if you experience a sharp or burning sore throat accompanied by other symptoms, especially if swallowing becomes difficult, consider the following steps:
Remember that bacterial infections can also cause sore throats and require antibiotic treatment. Since COVID-19 is a viral infection, antibiotics are ineffective. Avoid self-medicating and consult a doctor for proper diagnosis and treatment.
Vaccination remains the most effective strategy to protect against severe illness, hospitalization, and death from the Nimbus variant. Current COVID-19 vaccines, particularly those with updated boosters, continue to offer significant protection. Vaccinated individuals who contract the Nimbus variant generally experience milder symptoms.
Newer articles
Older articles